Q32 Bio Inc.
DE ˙ DB
12,10 € ↑1,70 (16,35%)
2026-06-05
DEL PRIS
SecurityDE:DB0 / Q32 Bio Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership118,152 shares
Latest Disclosed Value $ 758,740
Geode Capital Management, Llc reports 11.35% increase in ownership of DB0 / Q32 Bio Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 118,152 shares of Q32 Bio Inc. (DE:DB0) valued at $632,113 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 106,113 shares of Q32 Bio Inc.. This represents a change in shares of 11.35% during the quarter. The current value of the position is $1,429,639 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F Q32 BIO COM 746964105 118,152 12,039 11.35 759 115.34 0.0000
2026-02-09 2025-12-31 13F Q32 BIO COM 746964105 106,113 17,617 19.91 352 101.14 0.0000
2025-11-12 2025-09-30 13F Q32 BIO COM 746964105 88,496 26,897 43.66 175 92.31 0.0000
2025-08-08 2025-06-30 13F Q32 BIO COM 746964105 61,599 -75,910 -55.20 92 -59.73 0.0000
2025-05-13 2025-03-31 13F Q32 BIO COM 746964105 137,509 4,246 3.19 227 -50.66 0.0000
2025-02-12 2024-12-31 13F Q32 BIO COM 746964105 133,263 1,495 1.13 459 -92.21 0.0000
2024-11-12 2024-09-30 13F Q32 BIO COM 746964105 131,768 24,114 22.40 5,881 204.35 0.0005
2024-08-09 2024-06-30 13F Q32 BIO COM 746964105 107,654 89,688 499.21 1,932 531.37 0.0002
2024-05-13 2024-03-31 13F Q32 BIO COM 746964105 17,966 17,966 306 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.